The 20 Best HER2 Negative Breast Cancer Doctors Near Me in Worcester, MA

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as an Elite provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer. Dr. Lin is board certified in Medical Oncology.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Tolaney is board certified in Medical Oncology.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Partridge is board certified in Medical Oncology.

Matthew Yurgelun is an Oncologist practicing medicine in Milford, Massachusetts. Dr. Yurgelun is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Lynch Syndrome, Pancreatic Cancer, Familial Pancreatic Cancer, Colonoscopy, and Endoscopy.

Katharine Germansky is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Germansky is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, Crohn's Disease, DICER1 Syndrome, and Colonoscopy. Dr. Germansky is board certified in American Board Of Internal Medicine.

Nadine Tung is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Tung is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Tung is board certified in American Board Of Internal Medicine.

Rochelle Scheib is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Scheib is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Scheib is board certified in Internal Medicine, Medical Oncology, and Hematology.

Douglas Micalizzi is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Micalizzi is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses BRCA Positive Breast Cancer, Li-Fraumeni Syndrome, HER2 Negative Breast Cancer, and Phacomatosis Pigmentokeratotica. Dr. Micalizzi is board certified in Internal Medicine and Medical Oncology.

Dr. Nakhlis received her medical degree from Rush Medical College in Chicago in 1996. She subsequently completed her residency in general surgery and her breast surgery fellowship at Northwestern University in Chicago. She is an attending physician in the Brigham and Women's Hospital and Brigham and Women’s Faulkner Hospital in Boston and an assistant professor of surgery at Harvard Medical School. Her clinical research interests are focused on lobular neoplasia and other premalignant and proliferative breast lesions, and inflammatory breast cancer. Dr. Nakhlis is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Intraductal Papilloma, Mastectomy, and Lymphadenectomy. Dr. Nakhlis is board certified in Surgery, General.

Gerburg Wulf is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Wulf is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT). Dr. Wulf is board certified in American Board Of Internal Medicine.

Dr. Sammons is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer. She has led multiple clinical trials which have led to new treatment options for patients with metastatic breast cancer. She also has expertise in the treatment of brain metastases. Dr. Sammons received her MD from Sidney Kimmel Medical College in Philadelphia, PA in 2012. She completed her residency in internal medicine at University of Maryland and went on to complete fellowship in medical oncology and hematology at Duke University. In 2018, she joined the staff of Duke Cancer Institute and ultimately served as Associate Director of Breast Cancer Research. She joined Brigham and Women's and Dana-Farber in 2022, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. She serves as Associate Director of the Metastatic Breast Cancer Program. Dr. Sammons is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Paget Disease of the Breast. Dr. Sammons is board certified in Internal Medicine and Medical Oncology.

Dejan Juric is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Juric is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Breast Cancer, HER2 Negative Breast Cancer, Tissue Biopsy, and Lithotripsy.

Kathy Theall is an Oncologist practicing medicine in Cambridge, Massachusetts. Dr. Theall is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses HER2 Negative Breast Cancer, Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Infantile Neutropenia.

Judy Garber is a Hematologist practicing medicine in Chestnut Hill, Massachusetts. Dr. Garber is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, BRCA Positive Breast Cancer, and Peutz-Jeghers Syndrome.

Leif Ellisen is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Ellisen is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, and Triple-Negative Breast Cancer.

Huma Rana is a Medical Genetics provider practicing medicine in Boston, Massachusetts. Dr. Rana is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Li-Fraumeni Syndrome, HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, and Phacomatosis Pigmentovascularis. Dr. Rana is currently accepting new patients.

Michelle Specht is a General Surgeon and a Surgical Oncologist practicing medicine in Boston, Massachusetts. Dr. Specht is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Specht is board certified in Surgery, General.

Ellie Kwak is a Radiologist practicing medicine in Boston, Massachusetts. Dr. Kwak is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Galactocoele, Breast Lump, Osteopenia, and Melorheostosis with Osteopoikilosis.

Himanshu Gupta is a Radiologist practicing medicine in Salem, Massachusetts. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Chronic Cough, Galactocoele, Vertigo, and HER2 Negative Breast Cancer.

Ann Joyce is an Internal Medicine provider practicing medicine in Chelmsford, Massachusetts. Dr. Joyce is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Bile Duct Obstruction, Bile Duct Stricture, Cholestasis, Endoscopy, and Pancreatectomy. Dr. Joyce is board certified in American Board Of Internal Medicine.